| ¿µ¹® | United States Pharmacopeia(U.S.P.) | ÇÑ±Û | ¹Ì±¹¾àÀü |
|---|---|---|---|
| ¼³¸í | ¹Ì±¹¾àÀüȸÀÇ¿¡¼ ¹ßÇàÇÏ´Â ¾à¹°ÀÇ ±âÁØÀ» ³ªÅ¸³»´Â °øÀÎµÈ ±Ô°ÝÀ¸·Î¼ Á¤±âÀûÀ¸·Î °³Á¤µÈ´Ù. °¢Á¾ ¾à¹°ÀÇ °µµ, Á¤¼º, ºÒ¼ø¹°ÀÇ ¾çÀ» ±ÔÁ¤Å°À§ÇÑ °Ë»ç¹ý µîÀÌ ±âÀçµÇ¾î ÀÖ´Ù. |
||
| ¿µ¹® | Dilatation and Curettage(D & C) | ÇÑ±Û | Àڱñܾ¼ú, ÀڱøñÈ®Àå |
|---|---|---|---|
| ¼³¸í | ÀÚ±ÃÀ̶õ žư¡ ¼öÅÂµÇ¾î¼ ºÐ¸¸Àü±îÁö ¹ßÀ°ÇÏ°í ¼ºÀåÇÏ´Â °ø°£ÀÌ´Ù. Àڱüӿ¡ º´º¯ÀÌ ÀÖ¾î ÀÓ½ÅÀÌ °è¼ÓµÉ ¼ö ¾ø°Å³ª ¾Æ´Ï¸é ´Ù¸¥ ÀÌÀ¯·Î ÀӽŵǾî Àִ žƸ¦ Á¦°ÅÇϰíÀÚ ÇÒ °æ¿ì¿¡ »ç¿ëµÇ´Â ¹æ¹ýÀÌ´Ù. ¿©±â¼ ±Ü¾î³»±â À§ÇÏ¿©´Â ¿ì¼± ÀÚ±ÃÀÇ ÀÔ±¸¿¡ ÇØ´çÇÏ´Â ÀڱøñÀ» È®Àå½ÃÄÑ¾ß ÇÑ´Ù. ¿©±â¿¡´Â ±Þ¼ÓÈ÷ È®ÀåÀ» ½ÃµµÇÏ´Â ¹ý°ú ¼¼È÷ È®ÀåÀ» ½ÃµµÇÏ´Â 2°¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ÀڱøñÀ» ±Þ¼ÓÈ÷ È®ÀåÇÒ ¶§´Â Çì°¡¸£ ¸ñ°üÈ®Àå±â(Hegar's dilatator)¸¦ »ç¿ëÇÑ´Ù. À̰ÍÀº ÀÛÀº ±Ý¼Ó¸·´ë·Î ÀÛÀº Å©±âºÎÅÍ Å« Å©±â±îÁö ´Ù¾çÇÑ Å©±â°¡ ÀÖ¾î¼ ¿ì¼± ÀÛÀº ¸·´ë·Î ½ÃÀÛÇÏ¿© Á¡Á¡ Å« Å©±âÀÇ ¸·´ë¸¦ Àڱøñ¿¡ ³Ö¾î¼ ÀڱøñÀ» È®Àå½ÃŲ´Ù. ¼¼È÷ È®Àå½Ãų ¶§´Â Laminaria tent¸¦ ¸ñ°ü¿¡ »ðÀÔÇÏ´Â ¹æ¹ýÀ» »ç¿ëÇÑ´Ù. Laminaria tent¶õ ÇØÃÊ·Î ¸¸µç ÀÛÀº ¸·´ë·Î ¼öºÐÀ» Èí¼öÇϸé Á¡Á¡ ´Ã¾î³ª´Â ¼ºÁúÀÌ ÀÖ´Ù. À̰ÍÀ» ÀÚ±ÃÀÇ ¸ñ¿¡ ³ÖÀ¸¸é À̰ÍÀÌ ¼öºÐÀ» Èí¼öÇÏ¿© ´Ã¾î³ª¹Ç·Î õõÈ÷ ÀÚ±ÃÀÇ ¸ñÀÌ ´Ã¾î³´Ù. ÀڱøñÀÌ ÃæºÐÈ÷ ´Ã¾î³ª¸é ±× ¼ÓÀ¸·Î ³¡ÀÌ ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ ³Ö¾î¼ ÀڱüÓÀÇ º´º¯À̳ª ÀÓ½ÅµÈ Å¾Ƹ¦ ±Ü¾î³»´Âµ¥ ¿©±â¿¡ »ç¿ëµÇ´Â ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ Å¥·¿À̶ó°í ÇÑ´Ù. Ãʱâ ÀÓ½ÅÁßÀý Áï À¯»ê°ú °°Àº ÀӽŰú °ü·ÃµÈ °æ¿ì»Ó¸¸ ¾Æ´Ï¶ó, ºñÀӽŠÀÚ±ÃÀÇ Àڱ󻸷Á¶Á÷ÀÇ Ã¤Ãë ¹× Á¦°Å¸¦ À§Çؼµµ ÇàÇØÁö´Â ¼ö±âÀÌ´Ù. ÀÌ´Â ¿øÄ¢ÀûÀ¸·Î ¸¶ÃëÇÏ¿¡ ½Ç½ÃµÇ´Â °ÍÀ¸·Î Àڱøñ°üÀ» È®ÀåÇÏ°í ±â±¸·Î Àڱà ³»¿ë¹°À» Á¦°ÅÇϰí Å¥·¿À¸·Î Àڱ󻺮À» ±ú²ýÀÌ ÇÑ´Ù. ÀÚ±Ãõ°øÀ̳ª ÀڱøñÀÇ ÆÄ¿ µîÀÇ À§ÇèÀÌ µû¸£¸ç, ¼ö¼úÈÄ °¨¿° ¶Ç´Â ÃâÇ÷ µî¿¡ ´ëÇÑ ÁÖÀǰ¡ ÇÊ¿äÇÏ´Ù. |
||
| CS | calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ... |
|---|---|
| USP | United States Pharmacopeial convention = United States Pharmacopeia; ¹Ì±¹ ¾àÀü |
| HMG, hMG | Human Menopausal Gonadotropin |
| HMG | high-mobility group; human menopausal gonadotropin; 3-hydroxy-3-methyl-glutaryl |
| hMG | human menopausal gonadotropin |
| HMG | CC)-human menopausal gonadotrophin |
|---|---|
| HMG | Human Menopausal Gonadotrophin |
| PEPI | Post-menopausal Estrogen/Progestin Interventions |
| HMG/HCG | human menopausal gonadotrophin/human chorionic gonadotropin |
| F | Female |
acute angle
| menopausal | Associated with or occasioned by the menopause. (05 Mar 2000) |
|---|---|
| menopausal syndrome | <syndrome> Recurring symptoms experienced by some women during the climacteric period; they include hot flashes, chills, headache, irritability, and depression. Synonym: climacteric syndrome. (05 Mar 2000) |
| climacteric | <plant biology> A particular stage of fruit ripening, characterised by a surge of respiratory activity and usually coinciding with full ripeness and flavour in the fruit. Its appearance is hastened by ethylene at low concentrations. (18 Nov 1997) |
| climacteric psychosis | An obsolete term for involutional psychosis associated with the climacteric. (05 Mar 2000) |
| climacteric syndrome | <syndrome> Recurring symptoms experienced by some women during the climacteric period; they include hot flashes, chills, headache, irritability, and depression. Synonym: climacteric syndrome. (05 Mar 2000) |
| human menopausal gonadotropin | A hormone of pituitary originally obtained from the urine of postmenopausal women now produced synthetically; used to induce ovulation. See: menotropins. (05 Mar 2000) |
| united states agency for health care policy and research | An agency of the public health service established in 1990 to "provide indexing, abstracting, translating, publishing, and other services leading to a more effective and timely dissemination of information on research, demonstration projects, and evaluations with respect to health care to public and private entities and individuals engaged in the improvement of health care delivery.." it supersedes the national centre for health services research. (12 Dec 1998) |
| united states dept. Of health and human services | A department of the united states government concerned with administering those agencies and offices having programs pertaining to health and human services. (12 Dec 1998) |
| united states food and drug administration | An agency of the public health service concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc. (12 Dec 1998) |
| united states health resources and services administration | A component of the public health service that provides leadership related to the delivery of health services and the requirements for and distribution of health resources, including manpower training. (12 Dec 1998) |
| united states national aeronautics and space administration | An independent federal agency established in 1958. It conducts research for the solution of problems of flight within and outside the earth's atmosphere and develops, constructs, tests, and operates aeronautical and space vehicles. (12 Dec 1998) |
| united states occupational safety and health administration | An office in the department of labour responsible for developing and establishing occupational safety and health standards. (12 Dec 1998) |
| united states substance abuse and mental health services administration | An agency of the public health service concerned with the overall planning, promoting, and administering of programs pertaining to substance abuse and mental health. It is commonly referred to by the acronym samhsa. On 1 october 1992, the united states alcohol, drug abuse, and mental health administration (adamha) became samhsa. (telephone communication with samhsa 7 april 1992) (12 Dec 1998) |
| baltic states | The collective name for the republics of estonia, latvia, and lithuania on the eastern shore of the baltic sea. (12 Dec 1998) |
| pacific states | The geographic designation for states bordering on or located in the pacific ocean. The states so designated are alaska, california, hawaii, oregon, and washington. (u.s. Geologic survey telephone communication) (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|